Selected research
Industry Research
PROTAC Technology Industry Research Report 2026
Market perspective
The global PROTAC Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the PROTAC Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the PROTAC Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the PROTAC Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of PROTAC Technology include Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix and C4 Therapeutics, Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global PROTAC Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to PROTAC Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PROTAC Technology Market by Company
Arvinas
Captor therapeutics
Pfizer
Amgen
Oerth Bio
Bayer
Kymera
Nurix
C4 Therapeutics, Inc.
Astellas Pharma Inc.
AbbVie
Kaituo Pharmaceutical
Betta Pharmaceuticals
Hengrui Medicine
BeiGene
Haichuang Pharmaceutical
East China Pharmaceutical Group
PROTAC Technology Segment by Type
Based on CRBN
Based on VHL
PROTAC Technology Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Pancreatic Cancer
Lymphoma
Androgenic Alopecia
Others
PROTAC Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PROTAC Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PROTAC Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PROTAC Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PROTAC Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Based on CRBN
- Based on VHL
Applications
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Lymphoma
- Androgenic Alopecia
- Others
Companies covered
- Arvinas
- Captor therapeutics
- Pfizer
- Amgen
- Oerth Bio
- Bayer
- Kymera
- Nurix
- C4 Therapeutics, Inc.
- Astellas Pharma Inc.
- AbbVie
- Kaituo Pharmaceutical
- Betta Pharmaceuticals
- Hengrui Medicine
- BeiGene
- Haichuang Pharmaceutical
- East China Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 PROTAC Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Based on CRBN
- 2.2.3 Based on VHL
- 2.3 PROTAC Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Breast Cancer
- 2.3.3 Prostate Cancer
- 2.3.4 Colorectal Cancer
- 2.3.5 Pancreatic Cancer
- 2.3.6 Lymphoma
- 2.3.7 Androgenic Alopecia
- 2.3.8 Others
- 2.4 Assumptions and Limitations
3 PROTAC Technology Breakdown Data by Type
- 3.1 Global PROTAC Technology Historic Market Size by Type (2021-2026)
- 3.2 Global PROTAC Technology Forecasted Market Size by Type (2027-2032)
4 PROTAC Technology Breakdown Data by Application
- 4.1 Global PROTAC Technology Historic Market Size by Application (2021-2026)
- 4.2 Global PROTAC Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global PROTAC Technology Market Perspective (2021-2032)
- 5.2 Global PROTAC Technology Growth Trends by Region
- 5.2.1 Global PROTAC Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 PROTAC Technology Historic Market Size by Region (2021-2026)
- 5.2.3 PROTAC Technology Forecasted Market Size by Region (2027-2032)
- 5.3 PROTAC Technology Market Dynamics
- 5.3.1 PROTAC Technology Industry Trends
- 5.3.2 PROTAC Technology Market Drivers
- 5.3.3 PROTAC Technology Market Challenges
- 5.3.4 PROTAC Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top PROTAC Technology Players by Revenue
- 6.1.1 Global Top PROTAC Technology Players by Revenue (2021-2026)
- 6.1.2 Global PROTAC Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global PROTAC Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of PROTAC Technology Head Office and Area Served
- 6.4 Global PROTAC Technology Players, Product Type & Application
- 6.5 Global PROTAC Technology Manufacturers Established Date
- 6.6 Global PROTAC Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America PROTAC Technology Market Size (2021-2032)
- 7.2 North America PROTAC Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America PROTAC Technology Market Size by Country (2021-2026)
- 7.4 North America PROTAC Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe PROTAC Technology Market Size (2021-2032)
- 8.2 Europe PROTAC Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe PROTAC Technology Market Size by Country (2021-2026)
- 8.4 Europe PROTAC Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific PROTAC Technology Market Size (2021-2032)
- 9.2 Asia-Pacific PROTAC Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific PROTAC Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific PROTAC Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America PROTAC Technology Market Size (2021-2032)
- 10.2 South America PROTAC Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America PROTAC Technology Market Size by Country (2021-2026)
- 10.4 South America PROTAC Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa PROTAC Technology Market Size (2021-2032)
- 11.2 Middle East & Africa PROTAC Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa PROTAC Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa PROTAC Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Arvinas
- 12.1.1 Arvinas Company Information
- 12.1.2 Arvinas Business Overview
- 12.1.3 Arvinas Revenue in PROTAC Technology Business (2021-2026)
- 12.1.4 Arvinas PROTAC Technology Product Portfolio
- 12.1.5 Arvinas Recent Developments
- 12.2 Captor therapeutics
- 12.2.1 Captor therapeutics Company Information
- 12.2.2 Captor therapeutics Business Overview
- 12.2.3 Captor therapeutics Revenue in PROTAC Technology Business (2021-2026)
- 12.2.4 Captor therapeutics PROTAC Technology Product Portfolio
- 12.2.5 Captor therapeutics Recent Developments
- 12.3 Pfizer
- 12.3.1 Pfizer Company Information
- 12.3.2 Pfizer Business Overview
- 12.3.3 Pfizer Revenue in PROTAC Technology Business (2021-2026)
- 12.3.4 Pfizer PROTAC Technology Product Portfolio
- 12.3.5 Pfizer Recent Developments
- 12.4 Amgen
- 12.4.1 Amgen Company Information
- 12.4.2 Amgen Business Overview
- 12.4.3 Amgen Revenue in PROTAC Technology Business (2021-2026)
- 12.4.4 Amgen PROTAC Technology Product Portfolio
- 12.4.5 Amgen Recent Developments
- 12.5 Oerth Bio
- 12.5.1 Oerth Bio Company Information
- 12.5.2 Oerth Bio Business Overview
- 12.5.3 Oerth Bio Revenue in PROTAC Technology Business (2021-2026)
- 12.5.4 Oerth Bio PROTAC Technology Product Portfolio
- 12.5.5 Oerth Bio Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in PROTAC Technology Business (2021-2026)
- 12.6.4 Bayer PROTAC Technology Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Kymera
- 12.7.1 Kymera Company Information
- 12.7.2 Kymera Business Overview
- 12.7.3 Kymera Revenue in PROTAC Technology Business (2021-2026)
- 12.7.4 Kymera PROTAC Technology Product Portfolio
- 12.7.5 Kymera Recent Developments
- 12.8 Nurix
- 12.8.1 Nurix Company Information
- 12.8.2 Nurix Business Overview
- 12.8.3 Nurix Revenue in PROTAC Technology Business (2021-2026)
- 12.8.4 Nurix PROTAC Technology Product Portfolio
- 12.8.5 Nurix Recent Developments
- 12.9 C4 Therapeutics, Inc.
- 12.9.1 C4 Therapeutics, Inc. Company Information
- 12.9.2 C4 Therapeutics, Inc. Business Overview
- 12.9.3 C4 Therapeutics, Inc. Revenue in PROTAC Technology Business (2021-2026)
- 12.9.4 C4 Therapeutics, Inc. PROTAC Technology Product Portfolio
- 12.9.5 C4 Therapeutics, Inc. Recent Developments
- 12.10 Astellas Pharma Inc.
- 12.10.1 Astellas Pharma Inc. Company Information
- 12.10.2 Astellas Pharma Inc. Business Overview
- 12.10.3 Astellas Pharma Inc. Revenue in PROTAC Technology Business (2021-2026)
- 12.10.4 Astellas Pharma Inc. PROTAC Technology Product Portfolio
- 12.10.5 Astellas Pharma Inc. Recent Developments
- 12.11 AbbVie
- 12.11.1 AbbVie Company Information
- 12.11.2 AbbVie Business Overview
- 12.11.3 AbbVie Revenue in PROTAC Technology Business (2021-2026)
- 12.11.4 AbbVie PROTAC Technology Product Portfolio
- 12.11.5 AbbVie Recent Developments
- 12.12 Kaituo Pharmaceutical
- 12.12.1 Kaituo Pharmaceutical Company Information
- 12.12.2 Kaituo Pharmaceutical Business Overview
- 12.12.3 Kaituo Pharmaceutical Revenue in PROTAC Technology Business (2021-2026)
- 12.12.4 Kaituo Pharmaceutical PROTAC Technology Product Portfolio
- 12.12.5 Kaituo Pharmaceutical Recent Developments
- 12.13 Betta Pharmaceuticals
- 12.13.1 Betta Pharmaceuticals Company Information
- 12.13.2 Betta Pharmaceuticals Business Overview
- 12.13.3 Betta Pharmaceuticals Revenue in PROTAC Technology Business (2021-2026)
- 12.13.4 Betta Pharmaceuticals PROTAC Technology Product Portfolio
- 12.13.5 Betta Pharmaceuticals Recent Developments
- 12.14 Hengrui Medicine
- 12.14.1 Hengrui Medicine Company Information
- 12.14.2 Hengrui Medicine Business Overview
- 12.14.3 Hengrui Medicine Revenue in PROTAC Technology Business (2021-2026)
- 12.14.4 Hengrui Medicine PROTAC Technology Product Portfolio
- 12.14.5 Hengrui Medicine Recent Developments
- 12.15 BeiGene
- 12.15.1 BeiGene Company Information
- 12.15.2 BeiGene Business Overview
- 12.15.3 BeiGene Revenue in PROTAC Technology Business (2021-2026)
- 12.15.4 BeiGene PROTAC Technology Product Portfolio
- 12.15.5 BeiGene Recent Developments
- 12.16 Haichuang Pharmaceutical
- 12.16.1 Haichuang Pharmaceutical Company Information
- 12.16.2 Haichuang Pharmaceutical Business Overview
- 12.16.3 Haichuang Pharmaceutical Revenue in PROTAC Technology Business (2021-2026)
- 12.16.4 Haichuang Pharmaceutical PROTAC Technology Product Portfolio
- 12.16.5 Haichuang Pharmaceutical Recent Developments
- 12.17 East China Pharmaceutical Group
- 12.17.1 East China Pharmaceutical Group Company Information
- 12.17.2 East China Pharmaceutical Group Business Overview
- 12.17.3 East China Pharmaceutical Group Revenue in PROTAC Technology Business (2021-2026)
- 12.17.4 East China Pharmaceutical Group PROTAC Technology Product Portfolio
- 12.17.5 East China Pharmaceutical Group Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst